4.24
-0.06(-1.40%)
Currency In USD
| Previous Close | 4.3 |
| Open | 4.29 |
| Day High | 4.3 |
| Day Low | 4.17 |
| 52-Week High | 17.38 |
| 52-Week Low | 3.82 |
| Volume | 4,045 |
| Average Volume | 190,698 |
| Market Cap | 40.05M |
| PE | -0.55 |
| EPS | -7.74 |
| Moving Average 50 Days | 5.58 |
| Moving Average 200 Days | 6.06 |
| Change | -0.06 |
If you invested $1000 in Verrica Pharmaceuticals Inc. (VRCA) since IPO date, it would be worth $242.29 as of September 30, 2025 at a share price of $4.24. Whereas If you bought $1000 worth of Verrica Pharmaceuticals Inc. (VRCA) shares 5 years ago, it would be worth $547.8 as of September 30, 2025 at a share price of $4.24.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Verrica Pharmaceuticals Announces That Development Partner, Torii Pharmaceutical, Receives Approval for YCANTH® (TO-208) in Japan for the Treatment of Molluscum Contagiosum
GlobeNewswire Inc.
Sep 19, 2025 12:00 PM GMT
– Approval triggers $10 million cash milestone payment to Verrica – – YCANTH® approval in Japan addresses significant unmet need of patients with molluscum – – Verrica maintains ownership of global rights to YCANTH for all indications in all territor
Verrica Pharmaceuticals to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire Inc.
Sep 02, 2025 11:00 AM GMT
WEST CHESTER, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing and selling medications for skin diseases requiring medical interventions, today announced
Verrica Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide a Corporate Update on August 12, 2025
GlobeNewswire Inc.
Aug 06, 2025 11:00 AM GMT
WEST CHESTER, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announ